Xiaofeng Li
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Viral Infections and Vectors
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 12
- COVID-19 Clinical Research Studies 10
- Viral gastroenteritis research and epidemiology 6
- SARS-CoV-2 detection and testing 5
- Viral Infections and Vectors 4
- Epidemiology 13
- Influenza Virus Research Studies 5
- Respiratory viral infections research 4
- Co-authors
- Hong Shan (4 shared papers)Fei Xiao (4 shared papers)Xiaobin Zheng (2 shared papers)Ye Liu (3 shared papers)Meiwen Tang (1 shared paper)Cheng‐Feng Qin (22 shared papers)Yong‐Qiang Deng (13 shared papers)Zhixiang Yan (6 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Journal of Fungi (2 papers)PLoS ONE (2 papers)Cell Discovery (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaofeng Li
85 papers receiving 4.6k citations
Xiaofeng Li's Hit Papers
Peers
Comparison fields: 5 of 152
- Infectious Diseases 2.5k
- Neurology 692
- General Dentistry 46
- Modeling and Simulation 107
- Biological Psychiatry 52
Countries citing papers authored by Xiaofeng Li
This map shows the geographic impact of Xiaofeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Li more than expected).
Fields of papers citing papers by Xiaofeng Li
This network shows the impact of papers produced by Xiaofeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Li. The network helps show where Xiaofeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evidence for Gastrointestinal Infection of SARS-CoV-2 Hit paper breakdown → | 2020 | 2156 |
| 2 | Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Hit paper breakdown → | 2020 | 711 |
| 3 | 2016 | 237 | |
| 4 | 2015 | 110 | |
| 5 | 2020 | 103 | |
| 6 | 2015 | 97 | |
| 7 | 2016 | 85 | |
| 8 | 2012 | 82 | |
| 9 | 2017 | 80 | |
| 10 | 2021 | 54 | |
| 11 | 2021 | 54 | |
| 12 | 2007 | 49 | |
| 13 | 2015 | 48 | |
| 14 | 2024 | 48 | |
| 15 | 2017 | 47 | |
| 16 | 2022 | 38 | |
| 17 | 2021 | 36 | |
| 18 | 2017 | 34 | |
| 19 | Ban-Lan-Gen Granule Alleviates Dextran Sulfate Sodium-Induced Chronic Relapsing Colitis in Mice via Regulating Gut Microbiota and Restoring Gut SCFA Derived-GLP-1 Production | 2022 | 32 |
| 20 | 2021 | 32 |
About Xiaofeng Li
Xiaofeng Li is a scholar working on Infectious Diseases, Epidemiology, Immunology, Molecular Biology and Genetics, having authored 90 papers that have together received 4.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (10 papers), Viral gastroenteritis research and epidemiology (6 papers), Influenza Virus Research Studies (5 papers), SARS-CoV-2 detection and testing (5 papers), Viral Infections and Vectors (4 papers), Gut microbiota and health (4 papers) and Respiratory viral infections research (4 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), Neurology (692 citations), General Dentistry (46 citations), Modeling and Simulation (107 citations) and Biological Psychiatry (52 citations). Xiaofeng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hong Shan, Fei Xiao, Xiaobin Zheng, Ye Liu, Meiwen Tang, Cheng‐Feng Qin, Yong‐Qiang Deng, Zhixiang Yan, Zhenyi Zhang and Lin Lü. Their work appears in journals such as Signal Transduction and Targeted Therapy, Journal of Fungi, PLoS ONE, Cell Discovery and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.